News
Annual Results as of 31 March 2025 / Successful Business Year 2024/25
EQS-News: SCHOTT Pharma delivers strong second quarter of fiscal year 2025
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
Targeted adjustments to the ‘Rocket & Tigerli’ construction project
EQS-News: After Significant Adjustments to the Corporate Structure: Voltabox Achieves Key Milestones in the Turnaround in Q1 2025
SKAN provides in-depth insight into its growth strategy and pre-approved services on its first Capital Market Day
2024/2025 financial year: HBM Healthcare achieved profit of CHF 19 million in a challenging environment
Avolta reports strong first quarter 2025, with CORE turnover growth of +8.2% CER, EBITDA margin of 6.4%, +37bps YoY, and reaffirms outlook
United Bankshares, Inc. Holds Annual Meeting of Shareholders
United Bankshares, Inc. (“United”) (NASDAQ: UBSI), an approximately $33 billion regional financial services company, held its Annual Meeting of Shareholders on Wednesday, May 14, 2025, at
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
AbCellera (Nasdaq: ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial Application (CTA) for ABCL635, an investigational antibody
Oceaneering to Participate at Citi’s 2025 Spotlight on SMID Energy Day
Oceaneering International, Inc. ("Oceaneering") (NYSE:OII) announced today that Senior Vice President and Chief Financial Officer Alan R. Curtis and Senior Investor Relations Director Hilary
GeoPark Provides Update on Transaction in Vaca Muerta, Argentina
GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent energy company with over 20 years of successful operations across Latin America, announces today that Phoenix Global
Cushman & Wakefield Hires Rich Okoney as Global Data Center Facilities Management Practice Lead
Rich Okoney has joined Cushman & Wakefield (NYSE: CWK) as Global Data Center Practice Lead in the firm’s Integrated Facility Management (IFM) Service Line team. Based in Connecticut, Okoney will
State Street Corporation Declares Dividends on its Common Stock and Non-Cumulative Perpetual Preferred Stock Series “G,” “I,” “J,” and “K”
State Street Corporation (NYSE:STT) today announced a quarterly cash dividend of $0.76 per share of common stock, payable on July 11, 2025 to common shareholders of record at the close of business
Customers Bancorp, Inc. Announces Full Redemption of Series E Preferred Stock
Customers Bancorp, Inc. (NYSE: CUBI) is redeeming, in whole, all 2,300,000 shares ($57.5 million) of its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series E (ticker “CUBIPrE”)
Xylem Inc. Declares Second Quarter Dividend of 40 Cents per Share
The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a second quarter dividend of $0.40 per share payable on June 26, 2025, to shareholders of record as of May 29, 2025.
About Xylem
Jack in the Box Inc. Reports Second Quarter 2025 Earnings
Jack in the Box Inc. (NASDAQ: JACK) announced financial results for the Jack in the Box and Del Taco brands in the second quarter, ended April 13, 2025.
“I am encouraged by our marketing plans in
Kohl’s Corporation Declares Quarterly Dividend
The Board of Directors of Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today declared a regular quarterly dividend of $0.125 per share on the Company’s common stock. The dividend is
United Bankshares Declares Second Quarter Dividend
United Bankshares, Inc. (NASDAQ: UBSI) today announced that its Board of Directors declared a second quarter 2025 dividend of $0.37 per share for shareholders of record as of June 13, 2025.
The
PROS Unveils Revolutionary AI Agents to Transform Business Efficiency and User Engagement
PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing and selling solutions, today announced the launch of PROS AI Agents. Showcased at the company’s Outperform with PROS
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The
MaaT Pharma To Present Updated Data for MaaT013 in Early Access Program at the European Hematology Association (EHA) Annual Congress
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to
EQS-News: Shelly Group off to a strong start in financial year 2025 – Growth slightly above expectations
EQS-Adhoc: Brockhaus Technologies AG: Q1 2025 quarterly statement publication postponed to May 30, 2025; audit opinions 2024 issued for three operating Bikeleasing Group companies



